Fluoro Biotech
Fluoro Biotech is a South African biotech company that operates a heterologous protein production platform to supply local and international markets with proteins of interest. Founded in 2022 and based in Stellenbosch, it is an early-stage private company with 1–10 employees.
- Company typePrivate
- Founded2022
- HeadquartersStellenbosch, South Africa
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Fluoro Biotech does
Fluoro Biotech is a private, early-stage biotechnology company founded in 2022 and headquartered in Stellenbosch, South Africa. According to its firmographic description, the company operates a heterologous protein production platform intended to supply both local and international markets with proteins of interest. Heterologous expression — producing a protein in a host organism different from its natural source — is a foundational capability in recombinant protein manufacture, relevant to research reagents, diagnostic antigens, therapeutic candidates, and industrial enzymes.
The company is structured as a for-profit private entity with a small team of 1–10 employees, which is consistent with a lab-stage or pre-commercial operation. No specific products, SKUs, service offerings, pricing, customer segments, distribution channels, or management team members are disclosed in the available source data. The company's website (fluorobiotech.com) is listed but no detailed product or technical content was captured in the input.
Fluoro Biotech's first recorded funding event occurred in January 2024, involving the University Technology Fund as the disclosed investor, with a recorded transaction value of $0 — suggesting a non-dilutive, institutional, or seed-grant arrangement rather than a conventional priced equity round. No revenue, M&A activity, partnerships, certifications, patents, or regulatory actions are disclosed. The overall evidence base supports a characterization of Fluoro Biotech as a nascent spinout-stage platform with limited disclosed commercial traction.
Fluoro Biotech firmographics
Firmographics- Name
- Fluoro Biotech
- Website
- https://fluorobiotech.com
- Company type
- Private
- Founded year
- 2022
- Headcount range
- 1–10 employees
- Short description
- Fluoro Biotech is a South African biotech company that operates a heterologous protein production platform to supply local and international markets with proteins of interest. Founded in 2022 and based in Stellenbosch, it is an early-stage private company with 1–10 employees.
- Ownership category
- akta.pro rank
Where Fluoro Biotech is headquartered
LocationHeadquarters
- HQ city
- Stellenbosch
- HQ country
- South Africa
- HQ region
- Africa
Markets served
Fluoro Biotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Fluoro Biotech product offering
Product offeringCore offering
Fluoro Biotech provides a heterologous protein production platform used to manufacture and supply proteins of interest. The platform targets both local South African and international buyers in need of recombinant proteins for research and commercial applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Heterologous Protein Production Platform
Companies that use Fluoro Biotech
Customer profileIdeal customer profiles1 record
Fluoro Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Fluoro Biotech partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights2 records
Fluoro Biotech competitors and assessment
Company assessmentDirect peers
- GenScript: Global provider of recombinant protein production services and gene synthesis, with a similar custom protein expression platform serving research and therapeutic customers worldwide.
- ATUM: Synthetic biology and protein engineering company offering custom protein expression services and platform tools, closely aligned with Fluoro Biotech's heterologous protein production focus.
- ACROBiosystems: Producer of recombinant proteins and protein reagents for research and biopharma, with overlapping customer base and similar heterologous expression platform model.
- Sino Biological: Recombinant protein manufacturer offering catalog and custom proteins, directly comparable to Fluoro Biotech's heterologous protein production offering.
Broad incumbents
- Abcam: Established recombinant protein and antibody reagent supplier serving research customers with overlapping offerings.
- Thermo Fisher Scientific: Dominant biopharma services and reagents incumbent offering recombinant protein production as part of a much broader portfolio.
- Bio-Techne: Large life sciences tools company with deep recombinant protein catalog and custom services; competes broadly across the same end markets.
- Cytiva: Bioprocessing and protein production equipment/services incumbent supplying biopharma manufacturers globally; adjacent competitor in upstream protein production services.
Regional players
- Cape Bio Pharms: South African-based recombinant protein expression company producing reagents and research proteins; directly comparable regional peer operating from the same country.
- Afrigen Biologics: South African biologics manufacturer focused on vaccines and biological products; regional peer operating in the same South African biotech ecosystem with overlapping manufacturing capabilities.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Fluoro Biotech social profiles
Digital presenceFluoro Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fluoro Biotech leadership team
Management profileNumber of profiles
Fluoro Biotech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fluoro Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fluoro Biotech
What does Fluoro Biotech do?
Fluoro Biotech provides a heterologous protein production platform used to manufacture and supply proteins of interest. The platform targets both local South African and international buyers in need of recombinant proteins for research and commercial applications.
When was Fluoro Biotech founded?
Fluoro Biotech was founded in 2022. It employs 1 to 10 people.
Where is Fluoro Biotech based?
Fluoro Biotech is headquartered in Stellenbosch, South Africa, in the Africa region.
Who are Fluoro Biotech's main competitors?
Direct peers on record are GenScript, ATUM, ACROBiosystems and Sino Biological. Broad incumbents are Abcam, Thermo Fisher Scientific, Bio-Techne and Cytiva. Regional players are Cape Bio Pharms and Afrigen Biologics.
Does Fluoro Biotech have an API?
No public API is recorded for Fluoro Biotech.